Mullein's Antibacterial and Antimicrobial Action


Table of Contents

  1. Overview of Mullein Antibacterial Research
  2. Bacteria Tested in the Laboratory
  3. Relevance to Respiratory Pathogens
  4. Proposed Mechanisms of Action
  5. Antimicrobial Activity Across the Verbascum Genus
  6. Mullein in Herbal Ear-Infection Preparations
  7. Synergy and Combination Studies
  8. The In-Vitro Caveat — Lab Activity Is Not a Clinical Antibiotic
  9. Traditional Antimicrobial Uses
  10. Safety
  11. Research Papers and References
  12. Connections
  13. Featured Videos

Overview of Mullein Antibacterial Research

Common mullein (Verbascum thapsus) is best known as a soothing respiratory and ear herb, but it also carries a long folk reputation as an antimicrobial — poultices for infected wounds, washes for inflamed skin, and infused oils dripped into aching ears. Over the past three decades, laboratory researchers have begun to test whether those traditional uses have a measurable basis. The short answer is that mullein extracts do show antibacterial activity in the test tube, that the activity is modest to moderate compared with reference antibiotics, and that it varies considerably with the plant part used, the extraction solvent, and the bacterial species being challenged.

An influential early paper by Turker and Gurel (2005) reviewed the recent advances in the chemistry and pharmacology of Verbascum thapsus and summarized in-vitro screening showing activity against a range of bacteria. Their review, together with later genus-wide surveys, established that mullein is a legitimate subject of antimicrobial pharmacognosy rather than folklore alone. A more recent comprehensive review of Verbascum thapsus phytochemistry and bioactivity (published in Phytotherapy Research) reaffirmed that antibacterial and antiviral screening is one of the most-studied modern aspects of the plant, while emphasizing how heterogeneous the published results are.

It is important to frame all of this correctly from the outset. The evidence base for mullein's antibacterial action is almost entirely in vitro — experiments performed on bacteria growing in dishes and tubes. There are essentially no controlled human trials demonstrating that taking mullein cures a bacterial infection. The laboratory findings are biologically interesting and consistent with traditional use, but they describe what mullein constituents can do to bacteria in a controlled dish, not what a cup of mullein tea will do inside the human body.

Back to Table of Contents


Bacteria Tested in the Laboratory

When researchers screen a plant extract for antibacterial activity, they typically expose a panel of standardized reference bacterial strains to graded concentrations of the extract and measure either a zone of inhibition (in disc- or well-diffusion assays) or a minimum inhibitory concentration (MIC, the lowest concentration that stops visible growth). Mullein leaf, flower, and root extracts have been run through these assays against a fairly consistent panel of organisms across multiple studies.

The bacteria most frequently reported as susceptible to mullein extracts in vitro include the following. Each entry below describes a laboratory finding only:

Other organisms appearing in various mullein antibacterial papers include Streptococcus species, Enterococcus faecalis, Pseudomonas aeruginosa (typically resistant), and assorted environmental and food-spoilage bacteria. A recurring theme is that Gram-positive bacteria (staph, strep, bacillus) tend to be more susceptible than Gram-negative bacteria (E. coli, pseudomonas, klebsiella), which is a common pattern for plant phenolic and saponin extracts and is explained by the protective outer membrane of Gram-negative cells.

Back to Table of Contents


Relevance to Respiratory Pathogens

Mullein's primary traditional indication is respiratory — coughs, bronchitis, sore throat, and chest congestion — so the question of whether it acts against respiratory bacteria is of natural interest. Several of the organisms tested in mullein screens are relevant to the airway: Staphylococcus aureus can cause secondary respiratory infection, Klebsiella pneumoniae is a classic pneumonia organism, and Streptococcus species cause pharyngitis. In-vitro inhibition of these organisms is sometimes cited as a plausible link between mullein's antibacterial activity and its respiratory reputation.

However, the honest interpretation is more cautious. Mullein's well-documented benefit for the respiratory tract is most credibly attributed to its demulcent and expectorant actions — the mucilage coats and soothes irritated mucous membranes, and saponins help thin and mobilize mucus — rather than to direct killing of respiratory bacteria inside the lungs. A test-tube zone of inhibition against Klebsiella does not establish that drinking mullein tea reaches an infected lung at an inhibitory concentration. Most respiratory uses of mullein are best understood as symptomatic and soothing, with any antibacterial contribution being speculative at the level of human treatment.

For the antiviral side of mullein's respiratory story — which has its own distinct body of in-vitro work on influenza and other respiratory viruses — see the companion Antiviral Properties article.

Back to Table of Contents


Proposed Mechanisms of Action

Mullein contains several classes of constituents that could plausibly contribute to antibacterial activity, and the proposed mechanisms map onto well-understood pharmacology of plant defense compounds. No single "mullein antibiotic molecule" has been isolated; the activity is attributed to a mixture acting through more than one route.

Saponins and membrane disruption. Mullein is rich in triterpenoid saponins (such as the verbascosaponins). Saponins are surface-active, soap-like molecules that interact with sterols and lipids in cell membranes. In bacteria, saponins are thought to insert into and destabilize the cell membrane, increasing permeability and leaking essential contents — a relatively non-specific mechanism that helps explain activity across several species. This same membrane-active property contributes to mullein's expectorant effect on respiratory mucus.

Phenolic compounds and phenylethanoid glycosides. Mullein contains phenylethanoid glycosides (notably verbascoside, also called acteoside, and forsythoside), flavonoids (such as verbascoside-associated flavones), and other polyphenols. Phenolic compounds are widely associated with antibacterial activity through several routes: binding and inactivating bacterial enzymes and proteins, chelating metal ions the bacterium needs, generating oxidative stress, and interfering with the cell membrane and energy metabolism. Verbascoside in particular is a well-studied bioactive phenylethanoid with documented antioxidant and antimicrobial properties in the broader literature.

Iridoid glycosides and other constituents. Mullein also contains iridoid glycosides (such as aucubin and catalpol) and mucilage. Iridoids have shown a range of bioactivities in plants generally, and may contribute modestly to the overall antimicrobial profile, though they are studied more for anti-inflammatory and other effects. The net antibacterial activity of a whole mullein extract is best understood as the combined, possibly additive, output of saponins plus phenolics rather than any one isolated compound. A fuller breakdown of these constituents appears in the Active Compounds and Pharmacology article.

Back to Table of Contents


Antimicrobial Activity Across the Verbascum Genus

Common mullein is only one of roughly 360 species in the genus Verbascum, and antimicrobial screening has extended well beyond V. thapsus. Studies on species such as Verbascum sinaiticum, Verbascum lasianthum, Verbascum macrurum, Verbascum salviifolium, and others have reported in-vitro antibacterial and sometimes antifungal activity, frequently attributed to the same saponin and phenylethanoid-glycoside chemistry that characterizes the genus as a whole.

This genus-wide pattern is scientifically useful for two reasons. First, it strengthens the plausibility that the antibacterial activity of common mullein is a real chemical property of Verbascum constituents rather than an artifact of one study. Second, it highlights that results from one Verbascum species cannot be assumed to apply quantitatively to another, because the concentration and exact mix of saponins, iridoids, and phenylethanoids differ between species and even between populations of the same species grown in different conditions.

For someone reading the literature, this means that a paper reporting strong antibacterial activity for, say, Verbascum sinaiticum root is not direct evidence about common mullein leaf tea. The genus shares a chemical theme, but potency is species- and preparation-specific. This variability is one reason the field has not produced a standardized antibacterial mullein product.

Back to Table of Contents


Mullein in Herbal Ear-Infection Preparations

One of the most familiar real-world uses of mullein is as a component of herbal ear drops, typically a warm oil infused with mullein flowers, often combined with garlic and sometimes calendula, St. John's wort, or other herbs. These preparations are used traditionally for the discomfort of ear infections (otitis media and external-ear irritation). The rationale combines mullein's soothing, anti-inflammatory action with the antibacterial reputation of the combination, and a small body of clinical research has examined naturopathic herbal ear-drop blends for ear-infection pain in children.

It is worth being precise about what these ear-drop studies show. The better-known trials tested multi-herb formulas (mullein being one ingredient among several) primarily for pain relief in acute otitis media, and reported that the herbal drops were comparable to or better than anesthetic ear drops for symptomatic relief. They were not designed as, and do not constitute, evidence that mullein itself sterilizes the middle ear or cures the underlying bacterial infection. Most childhood ear infections also resolve on their own, which complicates interpretation of any pain-focused trial.

This site treats the ear-health topic in depth, including the structure of these preparations and what the clinical evidence does and does not support, in the dedicated Ear Health and Ear Infections article. For the purposes of this antibacterial page, the key point is that mullein's presence in ear-drop blends reflects its traditional antimicrobial and soothing reputation, supported by in-vitro activity, but the human evidence is about comfort rather than cure.

Back to Table of Contents


Synergy and Combination Studies

Because individual plant extracts are usually weaker than pharmaceutical antibiotics, a recurring research strategy is to test whether combining a plant extract with another agent produces a greater-than-additive (synergistic) effect. In the mullein and broader Verbascum literature, two kinds of combination studies appear in vitro: combinations of mullein with other antibacterial herbs (such as the classic mullein-plus-garlic ear-oil pairing), and combinations of plant extracts with conventional antibiotics to see whether the extract can lower the effective antibiotic dose or partially restore activity against resistant strains.

Some in-vitro work on plant phenolics and saponins generally — the chemical classes mullein belongs to — has found that these compounds can enhance the activity of certain antibiotics or disrupt bacterial efflux pumps and biofilms, which are mechanisms bacteria use to evade drugs. Where mullein or related Verbascum extracts have been tested in combination, the more favorable results tend to involve Gram-positive organisms and pair the extract with an agent that targets a different part of the cell.

These synergy findings are intriguing and fit the logic of why traditional remedies combine multiple herbs, but they remain laboratory observations. Combination effects measured on a checkerboard assay in a dish do not translate automatically into a clinical regimen, and none of this should be read as a recommendation to combine mullein with prescription antibiotics without medical supervision — see the safety section below.

Back to Table of Contents


The In-Vitro Caveat — Lab Activity Is Not a Clinical Antibiotic

This caveat deserves its own section because it is the single most important thing to understand about mullein's antibacterial action. Demonstrating that a plant extract inhibits bacteria in a petri dish is a long way from demonstrating that the plant treats infection in a person. Many plant extracts show in-vitro antibacterial activity at concentrations that are simply not achievable in human blood or tissue after drinking a tea or taking a capsule, because the active compounds are diluted, poorly absorbed, broken down by the liver, or never reach the infected site.

Several specific limitations apply to the mullein data:

The reasonable, evidence-aligned position is this: mullein has genuine, reproducible in-vitro antibacterial activity that is consistent with its traditional topical and ear uses and with its known chemistry; it is best regarded as a gentle, soothing supportive herb, not as a stand-alone treatment for bacterial infection.

Back to Table of Contents


Traditional Antimicrobial Uses

Long before MIC assays existed, mullein occupied a defined place in European, North American, and other traditional herbal practices for problems we would now describe as infectious or inflammatory. The leaves and flowers were the main parts used. Common traditional applications with an antimicrobial flavor include:

These traditional uses are valuable as hypotheses and as context, and they line up reasonably well with the in-vitro findings (notably the consistent activity against the Gram-positive skin organism Staphylococcus aureus, which is exactly the kind of bacterium relevant to infected wounds). Traditional use is a legitimate starting point for investigation, but it is not, by itself, proof of clinical efficacy. The deeper coverage of topical applications and the anti-inflammatory side of mullein appears in the Skin, Wounds and Inflammation article.

Back to Table of Contents


Safety

Mullein has a long record of traditional use and is generally regarded as a low-risk herb when used in customary amounts. Still, a few practical safety points are worth noting, especially in the context of any antimicrobial use:

Back to Table of Contents


Research Papers and References

The references below combine the two verifiable mullein review papers with curated PubMed topic-search links for the antibacterial specifics. Each search link opens directly in PubMed at the U.S. National Library of Medicine. Plant antibacterial findings cited here are in-vitro screening results unless a paper explicitly states otherwise.

  1. Turker AU, Gurel E (2005). Common mullein (Verbascum thapsus L.): recent advances in research. Phytotherapy Research. 19(9):733–739. — doi:10.1002/ptr.1653
  2. Comprehensive review of Verbascum thapsus phytochemistry and bioactivity. Phytotherapy Research. — doi:10.1002/ptr.7393
  3. Antibacterial activity of Verbascum thapsus against Staphylococcus aureusPubMed: Verbascum thapsus antibacterial Staphylococcus
  4. Antimicrobial activity across the Verbascum genus — PubMed: Verbascum antimicrobial activity
  5. Verbascum thapsus activity against methicillin-resistant Staphylococcus aureus (MRSA) — PubMed: Verbascum thapsus MRSA
  6. Verbascum extracts versus Gram-negative bacteria (Klebsiella, E. coli) — PubMed: Verbascum Klebsiella E. coli
  7. Verbascoside (acteoside) antimicrobial and antioxidant activity — PubMed: verbascoside antimicrobial
  8. Saponins and bacterial cell-membrane disruption — PubMed: saponins antibacterial membrane
  9. Herbal ear-drop preparations and otitis media (naturopathic formula trials) — PubMed: herbal ear drops otitis media
  10. Phenolic compounds, antibiotic synergy, and bacterial efflux/biofilm — PubMed: phenolics antibiotic synergy
  11. Verbascum thapsus — complete research listing — PubMed: Verbascum thapsus (all)

External Authoritative Resources

Back to Table of Contents


Connections

Back to Table of Contents